Prolonged sirolimus administration after allogeneic hematopoietic cell transplantation is associated with decreased risk for moderate-severe chronic graft-versus-host disease

Effective pharmacological strategies employed in allogeneic hematopoietic cell transplantation should prevent serious chronic graft-versus-host disease and facilitate donor-recipient immune tolerance. Based on demonstrated pro-tolerogenic activity, sirolimus (rapamycin) is an agent with promise to a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Haematologica
Main Authors: Pidala, Joseph, Kim, Jongphil, Alsina, Melissa, Ayala, Ernesto, Betts, Brian C., Fernandez, Hugo F., Field, Teresa, Jim, Heather, Kharfan-Dabaja, Mohamed A., Locke, Frederick L., Mishra, Asmita, Nishihori, Taiga, Ochoa-Bayona, Leonel, Perez, Lia, Riches, Marcie, Anasetti, Claudio
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2015
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4486232/
https://ncbi.nlm.nih.gov/pubmed/25840599
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2015.123588
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados